A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma

The molecular diversity exhibited by diffuse large B-cell lymphoma (DLBCL) is a significant obstacle facing current precision therapies. However, scoring using the International Prognostic Index (IPI) is inade...
Source: Lipids in Health and Disease - Category: Lipidology Authors: Tags: Research Source Type: research
More News: Lipidology | Lymphoma